199 related articles for article (PubMed ID: 36645209)
21. FcγRIIB inhibits inflammation in a murine model of psoriasis.
Nakabori I; Hamaguchi Y; Sawada K; Horii M; Fushida N; Kitano T; Chenyang W; Xibei J; Ikawa Y; Komuro A; Matsushita T
J Dermatol Sci; 2022 Nov; 108(2):87-97. PubMed ID: 36567222
[TBL] [Abstract][Full Text] [Related]
22. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.
Nadeem A; Al-Harbi NO; Al-Harbi MM; El-Sherbeeny AM; Ahmad SF; Siddiqui N; Ansari MA; Zoheir KM; Attia SM; Al-Hosaini KA; Al-Sharary SD
Pharmacol Res; 2015 Sep; 99():248-57. PubMed ID: 26149470
[TBL] [Abstract][Full Text] [Related]
23. Small interfering RNA targeting of keratin 17 reduces inflammation in imiquimod-induced psoriasis-like dermatitis.
Xiao CY; Zhu ZL; Zhang C; Fu M; Qiao HJ; Wang G; Dang EL
Chin Med J (Engl); 2020 Nov; 133(24):2910-2918. PubMed ID: 33237695
[TBL] [Abstract][Full Text] [Related]
24. Ginsenoside Rg1 abolish imiquimod-induced psoriasis-like dermatitis in BALB/c mice via downregulating NF-κB signaling pathway.
Shi Q; He Q; Chen W; Long J; Zhang B
J Food Biochem; 2019 Nov; 43(11):e13032. PubMed ID: 31502279
[TBL] [Abstract][Full Text] [Related]
25. Activation of Langerhans cells promotes the inflammation in imiquimod-induced psoriasis-like dermatitis.
Xiao C; Zhu Z; Sun S; Gao J; Fu M; Liu Y; Wang G; Yao X; Li W
J Dermatol Sci; 2017 Mar; 85(3):170-177. PubMed ID: 27964879
[TBL] [Abstract][Full Text] [Related]
26. Notch-Hes1 Signaling Regulates IL-17A
Wang Y; Li X; Xing X; Xue H; Qi R; Ji H; Ma L
Mediators Inflamm; 2020; 2020():8297134. PubMed ID: 32454795
[TBL] [Abstract][Full Text] [Related]
27. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice.
Gao J; Chen F; Fang H; Mi J; Qi Q; Yang M
Biol Res; 2020 Oct; 53(1):48. PubMed ID: 33081840
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis.
Niu XL; Huang Y; Gao YL; Sun YZ; Han Y; Chen HD; Gao XH; Qi RQ
Chin Med J (Engl); 2019 Mar; 132(6):690-698. PubMed ID: 30741833
[TBL] [Abstract][Full Text] [Related]
29. IL-27 activates Th1-mediated responses in imiquimod-induced psoriasis-like skin lesions.
Shibata S; Tada Y; Asano Y; Yanaba K; Sugaya M; Kadono T; Kanda N; Watanabe S; Sato S
J Invest Dermatol; 2013 Feb; 133(2):479-88. PubMed ID: 22951728
[TBL] [Abstract][Full Text] [Related]
30. Dual targeting of mTOR/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation.
Roy T; Banang-Mbeumi S; Boateng ST; Ruiz EM; Chamcheu RN; Kang L; King JA; Walker AL; Nagalo BM; Kousoulas KG; Esnault S; Huang S; Chamcheu JC
Front Immunol; 2022; 13():1075804. PubMed ID: 36741386
[TBL] [Abstract][Full Text] [Related]
31. A comparison of the effects of topical treatment of calcipotriol, camptothecin, clobetasol and tazarotene on an imiquimod-induced psoriasis-like mouse model.
Sun J; Dou W; Zhao Y; Hu J
Immunopharmacol Immunotoxicol; 2014 Feb; 36(1):17-24. PubMed ID: 24286371
[TBL] [Abstract][Full Text] [Related]
32. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.
Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z
Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330
[TBL] [Abstract][Full Text] [Related]
33. Ferulic acid altered IL-17A/IL-17RA interaction and protected against imiquimod-induced psoriasis-like skin injury in mice.
Lo HY; Li CC; Cheng HM; Liu IC; Ho TY; Hsiang CY
Food Chem Toxicol; 2019 Jul; 129():365-375. PubMed ID: 31054998
[TBL] [Abstract][Full Text] [Related]
34. The P2X7 receptor is not essential for development of imiquimod-induced psoriasis-like inflammation in mice.
Geraghty NJ; Mansfield KJ; Fuller SJ; Watson D; Sluyter R
Purinergic Signal; 2017 Dec; 13(4):405-415. PubMed ID: 28597172
[TBL] [Abstract][Full Text] [Related]
35. Topical Application of BMS-509744, a Selective Inhibitor of Interleukin-2-Inducible T Cell Kinase, Ameliorates Imiquimod-Induced Skin Inflammation in Mice.
Otake S; Otsubaki T; Uesato N; Ueda Y; Murayama T; Hayashi M
Biol Pharm Bull; 2021 Apr; 44(4):528-534. PubMed ID: 33473072
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory and Immunomodulatory Effects of Tripterygium wilfordii Multiglycoside in Mouse Models of Psoriasis Keratinocytes.
Zhang S; Li HJ; Yang CM; Liu L; Sun XY; Wang J; Chen ST; Lu Y; Hu MQ; Yan G; Zhou YQ; Miao X; Li X; Li B
Chin J Integr Med; 2024 Mar; 30(3):222-229. PubMed ID: 37597119
[TBL] [Abstract][Full Text] [Related]
37. Topical astilbin ameliorates imiquimod-induced psoriasis-like skin lesions in SKH-1 mice via suppression dendritic cell-Th17 inflammation axis.
Xu Q; Liu Z; Cao Z; Shi Y; Yang N; Cao G; Zhang C; Sun R; Zhang C
J Cell Mol Med; 2022 Feb; 26(4):1281-1292. PubMed ID: 35023281
[TBL] [Abstract][Full Text] [Related]
38. The therapeutic efficacy and mechanism action of Si Cao formula in the treatment of psoriasis: A pilot clinical investigation and animal validation.
Wu X; Zheng Q; Shen F; Song J; Luo Y; Fei X; Jiang W; Xie S; Ma X; Kuai L; Wang R; Ding X; Li M; Luo Y; Li B
J Ethnopharmacol; 2024 Apr; 323():117662. PubMed ID: 38160866
[TBL] [Abstract][Full Text] [Related]
39. Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis.
Swindell WR; Michaels KA; Sutter AJ; Diaconu D; Fritz Y; Xing X; Sarkar MK; Liang Y; Tsoi A; Gudjonsson JE; Ward NL
Genome Med; 2017 Mar; 9(1):24. PubMed ID: 28279190
[TBL] [Abstract][Full Text] [Related]
40. Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice.
Zhang S; Liu X; Mei L; Wang H; Fang F
BMC Complement Altern Med; 2016 Aug; 16(1):334. PubMed ID: 27581210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
